Perimenopause is the wrong place to wing it
The decade between 40 and 55 is the most important window for long-term hormonal and metabolic health. Here's why most women don't get the support they need — and what changes when they do.
The decade that decides the next forty
Perimenopause is not a single event. It's a 5–10 year transition that begins in many women in their early-to-mid 40s and continues through menopause and into the first post-menopausal years. The decisions made — or not made — during this window shape long-term cardiovascular, bone, metabolic, and cognitive health more than any other period after adolescence.
And most women navigate it with no support beyond "this is normal at your age."
What we actually know
- Estrogen decline in perimenopause directly affects bone density, cardiovascular risk, sleep architecture, mood, and cognitive function.
- Untreated perimenopausal symptoms are associated with worse long-term outcomes — not just lower quality of life now, but measurable health risk decades later.
- The Women's Health Initiative findings that cooled HRT prescribing in the 2000s have been substantially revisited. Modern bioidentical HRT is a different category of intervention than the conjugated equine estrogens those studies looked at.
- Hormone optimization works best when started early in the transition — not after symptoms have been ignored for years.
The IHS perimenopause approach
Three things, in order.
1. Full hormonal panel — repeated
Estrogen, progesterone, testosterone, DHEA, thyroid (full panel including reverse T3), cortisol pattern across the day. We repeat at intervals because hormones in perimenopause are not stable — single snapshots mislead.
2. Bioidentical hormone replacement, dose-personalized
Bioidentical estradiol, progesterone, and where appropriate testosterone — dosed to the patient's panels and symptoms, adjusted quarterly. Not generic dosing.
3. The non-hormone layers
Sleep protocol. Strength training cadence. Inflammatory diet adjustments. Specific micronutrient repletion (magnesium, vitamin D, B12, often iron). Stress and cortisol regulation. The hormones do their part — these protocols do the rest.
Who this is for
Women in their 40s and 50s who feel that something is shifting and aren't getting useful answers. Women on standard HRT who want a panel-driven, individually-titrated alternative. Women planning to start GLP-1 medication who want their hormonal baseline supported through the metabolic transition.
Book a private consultation. The first conversation is the lowest-pressure version of this — we listen, you talk, and we tell you honestly whether IHS is the right fit.